Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines
IntroductionColorectal cancer (CRC) is characterized by an extremely high mortality rate, mainly caused by the high metastatic potential of this type of cancer. To date, chemotherapy remains the backbone of the treatment of metastatic colorectal cancer. Three main chemotherapeutic drugs used for the...
Saved in:
| Main Authors: | Alexandra Razumovskaya, Mariia Silkina, Andrey Poloznikov, Timur Kulagin, Maria Raigorodskaya, Nina Gorban, Anna Kudryavtseva, Maria Fedorova, Boris Alekseev, Alexander Tonevitsky, Sergey Nikulin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Molecular Biosciences |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2025.1531175/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD44 knockdown alters miRNA expression and their target genes in colon cancer
by: Diana Maltseva, et al.
Published: (2025-05-01) -
Interplay of integrins and selectins in metastasis
by: Diana Maltseva, et al.
Published: (2025-06-01) -
Applications and perspectives of metastatic colorectal cancer organoids
by: CUI Jingwei, et al.
Published: (2024-06-01) -
Liver organoids: Current advances and future applications for hepatology
by: Yohan Kim, et al.
Published: (2025-02-01) -
Evaluation of chemotherapy drug efficacy using organoids model of colorectal cancer
by: GUO Yuehong, ZHOU Fanqi, WU Xi, ZHANG Guannan, WANG Fang, YU Jia
Published: (2025-04-01)